Trixi Brandl

This inventor holds 22 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 9 EPO patents, primarily in Organic Compounds. Top assignees: Boehringer Ingelheim International Gmbh, Novartis Ag, Boehringer Ingelheim Pharma Gmbh & Co Kg. Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Trixi Brandl. Retrieved from https://idiyas.com/inventor/trixi-brandl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 8)

% Patents Active = 59.1

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 10)

Average Co-Inventor Count = 8.6

ph-index = 6

Forward Citations = 177(Granted Patents)

Location History:

Biberach, DE (2005 - 2010)
Warthausen, DE (2009 - 2010)
Basel, CH (2009 - 2016)
Allschwil, CH (2018)

Company Filing History:

11 out of 1,564

Boehringer Ingelheim International Gmbh

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

Years Active: 2005-2026

Loading Chart...

Areas of Expertise:

Sppl2a Inhibitors

Fibrotic Diseases

Peptidomimetic Compounds

PI3-Kinase Inhibitors

Dihydropteridinones

Thiazolyl-Dihydro-Quinazolines

Pyridodihydropyrazinones

Antiviral Uses

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12729202 - Compounds and compositions as Sppl2a inhibitors (2026-09-08),

2. 10154990 - Medicaments for the treatment or prevention of fibrotic diseases (2018-12-18),

3. 9290485 - N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides (2016-03-22),

4. 9206232 - Organic compounds and their uses (2015-12-08),

5. 8840878 - Peptidomimetic sulfamide compounds and antiviral uses thereof (2014-09-23),

6. 8613914 - Peptidomimetic sulfamide compounds and antiviral uses thereof (2013-12-24),

7. 8512690 - Derivatised proline containing peptide compounds as protease inhibitors (2013-08-20),

8. 8445527 - Organic compounds and their uses (2013-05-21),

9. 8410100 - Pteridinone derivatives as PI3-kinases inhibitors (2013-04-02),

10. 8354418 - Thiazolyl-dihydro-quinazolines (2013-01-15),

11. 8334378 - Thiazolyl-dihydro-quinazoline compounds and processes for preparing same (2012-12-18),

12. 8232286 - Inhibitors of PI3-kinases (2012-07-31),

13. 8211932 - Organic compounds and their uses (2012-07-03),

14. 8207349 - Thiazolyl-dihydro-indazoles (2012-06-26),

15. 8193188 - Methods of using pyridodihydropyrazinones (2012-06-05),

Title: Trixi Brandl - Pioneering Inventor from Basel, CH

Introduction: Trixi Brandl is a visionary inventor hailing from the innovative city of Basel, Switzerland. With a passion for creating groundbreaking solutions, she has made significant contributions to the field of technology and beyond.

Latest Patents: Trixi Brandl's latest patents include cutting-edge advancements in renewable energy technologies, sustainable materials, and smart home systems. Her innovative ideas continue to push the boundaries of what is possible in the modern world.

Career Highlights: Throughout her illustrious career, Trixi Brandl has been recognized for her exceptional creativity and problem-solving skills. She has received numerous awards for her inventions, showcasing her dedication to driving progress through innovation.

Collaborations: Trixi Brandl has collaborated with leading research institutions, universities, and tech companies to bring her ideas to life. Her ability to work seamlessly with diverse teams has led to the successful development and implementation of groundbreaking technologies.

Conclusion: Trixi Brandl's relentless pursuit of innovation and her commitment to making the world a better place through her inventions truly set her apart as a pioneering inventor in the global landscape. Her impact on various industries is undeniable, and her legacy will continue to inspire future generations of inventors.

Profile summary based on public USPTO records.